Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: A post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
- Leiter, L.A.
- Bain, S.C.
- Hramiak, I.
- Jódar, E.
- Madsbad, S.
- Gondolf, T.
- Hansen, T.
- Holst, I.
- Lingvay, I.
Zeitschrift:
Cardiovascular Diabetology
ISSN: 1475-2840
Datum der Publikation: 2019
Ausgabe: 18
Nummer: 1
Art: Artikel
